The treatment of chronic illnesses commonly includes the long-term use of
pharmacotherapy. Although these medications are effective in combating disease, their full …

Cardiovascular disease is the leading cause of death globally. While pharmacological
advancements have improved the morbidity and mortality associated with cardiovascular …

Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …

Medication adherence usually refers to whether patients take their medications as
prescribed (eg, twice daily), as well as whether they continue to take a prescribed …

ABSTRACT BACKGROUND Non-adherence to essential medications represents an
important public health problem. Little is known about the frequency with which patients fail …

5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

ContextThe extent to which drug adherence may affect survival remains unclear, in part
because mortality differences may be attributable to “healthy adherer” behavioral attributes …

Context Depressive symptoms predict adverse cardiovascular outcomes in patients with
coronary heart disease, but the mechanisms responsible for this association are unknown …

Modern management of acute myocardial infarction is built on a clinical evidence base
drawn from many studies undertaken over the past three decades. The evolution in clinical …